Agilent Technologies (A) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00846U1016

Agilent Technologies, Inc. is a global company that specializes in providing specialized solutions to a variety of industries including life sciences, diagnostics, and applied chemical markets all over the world.

The company is structured into three main segments for more focused operations: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.

In the Life Sciences and Applied Markets segment, Agilent Technologies offers a wide range of advanced instruments and tools such as liquid chromatography systems, gas chromatography systems, mass spectrometry systems, laboratory software, and more, to cater to the needs of researchers and professionals in these sectors.

The Diagnostics and Genomics segment of Agilent Technologies focuses on genomic research, nucleic acid manufacturing, pathology services, and biomolecular analysis, providing comprehensive solutions to healthcare providers, researchers, and diagnostic professionals worldwide.

Additionally, the Agilent CrossLab segment of the company specializes in supplying GC and LC columns, sample preparation products, laboratory instrument supplies, and a range of tailored services including repairs, maintenance, installations, and software as a service, to ensure the efficient operation of laboratories and research facilities.

Agilent Technologies reaches its customers through various channels including direct sales, distributors, and e-commerce platforms, giving easy access to its innovative products and services. The company was established in 1999 and is headquartered in Santa Clara, California. For more information, visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Agilent Technologies (A) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Agilent Technologies (A) - Stock & Dividends

A Stock Overview

Market Cap in USD 42,250m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1999-11-18

A Stock Ratings

Growth 5y 4.94
Fundamental 7.82
Dividend 5.04
Rel. Performance vs Sector -0.29
Analysts 3.50/5
Fair Price Momentum 133.16 USD
Fair Price DCF 157.37 USD

A Dividends

Yield 12m 0.66%
Yield on Cost 5y 1.25%
Dividends CAGR 5y 6.27%
Payout Consistency 63.1%

A Growth Ratios

Growth 12m 0.75%
Growth Correlation 12m 29%
Growth Correlation 3m 53%
CAGR 5y 13.77%
Sharpe Ratio 12m -0.17
Alpha vs SP500 12m -21.67
Beta vs SP500 5y weekly 0.93
ValueRay RSI 31.43
Volatility GJR Garch 1y 23.99%
Price / SMA 50 -0.34%
Price / SMA 200 11.56%
Current Volume 1506k
Average Volume 20d 1423.7k

External Links for A Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of A stocks?
As of April 16, 2024, the stock is trading at USD 140.22 with a total of 1,506,028 shares traded.
Over the past week, the price has changed by -2.94%, over one month by -4.77%, over three months by +7.60% and over the past year by +1.46%.
What is the forecast for A stock price target?
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 147.8 in April 2025. The stock is currently trading at 140.22. This means that the stock has a potential upside of +5.41%.
Issuer Forecast Upside
Wallstreet Target Price 145.9 4.04%
Analysts Target Price 135.8 -3.19%
ValueRay Target Price 147.8 5.41%

Exploring Agilent Technologies: A Comprehensive Overview

History of Agilent Technologies

Agilent Technologies, Inc., often simply called Agilent, has a rich history that dates back to its inception in 1999. It was born as a spin-off from Hewlett-Packard (HP), carrying forward the legacy of innovation in electronics and serving as HP’s test- and measurement-equipment division before becoming an independent entity. This separation allowed Agilent to focus more intently on its core markets, including chemical analysis, life sciences, diagnostics, and electronics.

Core and Side Businesses

At its core, Agilent is dedicated to the development and manufacturing of analytical instruments, software, services, and consumables for the entire laboratory workflow. The company operates mainly within three segments:

  • Life Sciences and Applied Markets (LSAG): Provides instruments and software that serve a wide range of applications, including pharmaceutical, environmental, and food testing.
  • Diagnostics and Genomics (DGG): Offers solutions in diagnostic testing and genomics with a focus on precision medicine.
  • Agilent CrossLab (ACG): Delivers comprehensive services and consumables for laboratory efficiency and optimization.

Besides its core activities, Agilent has expanded into related businesses that complement its main operations. These include acquisitions and partnerships aimed at enhancing its product lines and expanding its technology offerings, thus maintaining a competitive edge in the market.

Current Market Status

As of now, Agilent Technologies, Inc. remains a global leader in the life sciences, diagnostics, and applied chemical markets. The company has demonstrated resilience and growth, benefiting from a strong product pipeline, strategic acquisitions, and a focus on customer-centric solutions. Agilent’s commitment to innovation has also enabled it to navigate challenges and capitalize on emerging scientific and technological trends. With its solid financial performance and strategic initiatives aimed at expanding global reach and enhancing operational efficiencies, Agilent continues to be well-positioned for future growth.